METHYLPREDNISOLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylprednisolone, and when can generic versions of Methylprednisolone launch?
Methylprednisolone is a drug marketed by Elkins Sinn, Organon Usa Inc, Amneal, Chartwell Rx, Duramed Pharms Barr, Endo Operations, Heather, Invatech, Jubilant Cadista, Novast Labs, Par Pharm, Praxgen, Sandoz, Tianjin Tianyao, Watson Labs, Zydus Pharms, Epic Pharma Llc, Eugia Pharma, Hong Kong, Sagent Pharms Inc, Teva Pharms Usa, Wilshire Pharms Inc, Abraxis Pharm, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Teva Parenteral, and Tianjin Kingyork. and is included in sixty-nine NDAs.
The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylprednisolone
A generic version of METHYLPREDNISOLONE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLPREDNISOLONE?
- What are the global sales for METHYLPREDNISOLONE?
- What is Average Wholesale Price for METHYLPREDNISOLONE?
Summary for METHYLPREDNISOLONE
| US Patents: | 0 |
| Applicants: | 29 |
| NDAs: | 69 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 830 |
| Patent Applications: | 4,377 |
| Drug Prices: | Drug price information for METHYLPREDNISOLONE |
| Drug Sales Revenues: | Drug sales revenues for METHYLPREDNISOLONE |
| What excipients (inactive ingredients) are in METHYLPREDNISOLONE? | METHYLPREDNISOLONE excipients list |
| DailyMed Link: | METHYLPREDNISOLONE at DailyMed |
See drug prices for METHYLPREDNISOLONE
Recent Clinical Trials for METHYLPREDNISOLONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Antwerp | Phase 3 |
| Kasr El Aini Hospital | N/A |
| Hospital General Universitario de Alicante | Phase 4 |
Pharmacology for METHYLPREDNISOLONE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for METHYLPREDNISOLONE
Anatomical Therapeutic Chemical (ATC) Classes for METHYLPREDNISOLONE
US Patents and Regulatory Information for METHYLPREDNISOLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089144-001 | Mar 28, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-005 | Jul 18, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 214297-001 | Jan 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 086159-001 | Feb 9, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 207667-001 | Dec 15, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
